Smith & Nephew Receives C1 Category Reimbursement Approval for OXINIUM(TM) in Japan

Smith & Nephew Receives C1 Category Reimbursement Approval for OXINIUM(TM) in Japan GENESIS II(TM) Knee System with OXINIUM to be marketed immediately TOKYO and MEMPHIS, Tenn., Sept. 3 /PRNewswire-FirstCall/ -- Smith & Nephew, Inc. (NYSE: SNN, LSE: SN) Orthopaedic Reconstruction & Trauma business and Smith & Nephew Orthopaedics KK Japan today announced that it has received Japanese regulatory C1 Category... [read full story]